SuperworthBecton, Dickinson and profit margin BDX
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 4.5%
- Operating margin, 12 months
- 9.6%
- Net margin on a year earlier
- −3.5 pts
- Peer median
- 17.0%
Over the twelve months to Jun 30, 2026, Becton, Dickinson and kept 4.5% of its revenue as net profit, with an operating margin of 9.6% and a gross margin of 46.4%.
Five years earlier its net margin was 10.0%.
The median for 10 medical instruments and supplies stocks of a similar size is 17.0%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 8.3% | 11.2% | 45.1% |
| FY2024 | 8.4% | 11.9% | 45.2% |
| FY2023 | 7.7% | 10.9% | 42.2% |
| FY2022 | 9.4% | 12.1% | 44.9% |
| FY2021 | 10.5% | 13.3% | 46.2% |
| FY2020 | 5.1% | 8.7% | 44.3% |
| FY2019 | 7.1% | 10.2% | 47.9% |
| FY2018 | 1.9% | 9.4% | 45.5% |
| FY2017 | 9.1% | 12.2% | 49.1% |
| FY2016 | 7.8% | 11.5% | 48.0% |
| FY2015 | 6.8% | 10.4% | 45.7% |
| FY2014 | 14.0% | 19.0% | 50.9% |
| FY2013 | 16.1% | 15.6% | 51.8% |
| FY2012 | 15.2% | 20.2% | 51.3% |
| FY2011 | 16.4% | 22.4% | 52.3% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q3 FY26 | 4.5% | −3.5 pts | 9.6% | |
| Q2 FY26 | 5.5% | −1.9 pts | 10.1% | |
| Q1 FY26 | 8.6% | +0.3 pts | 11.7% | |
| Q4 FY25 | 8.3% | −0.2 pts | 11.2% | |
| Q3 FY25 | 8.0% | +0.9 pts | 11.1% | |
| Q2 FY25 | 7.5% | +0.7 pts | 10.3% | |
| Q1 FY25 | 8.4% | +1.9 pts | 11.7% | |
| Q4 FY24 | 8.4% | +0.8 pts | 11.9% | |
| Q3 FY24 | 7.1% | −1.6 pts | 10.7% | |
| Q2 FY24 | 6.8% | −1.8 pts | 10.5% | |
| Q1 FY24 | 6.4% | −2.2 pts | 10.1% | |
| Q4 FY23 | 7.7% | −1.8 pts | 10.9% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Becton, Dickinson and's size, closest first, today.
| Company | Profit margin |
|---|---|
| BDXBecton, Dickinson and | 4.5% |
| MDLNMedline | n/m |
| RMDResMed | 26.9% |
| WSTWest Pharmaceutical Services | 17.0% |
| ISRGIntuitive Surgical | 25.5% |
| SOLVSolventum | 17.3% |
| PENPenumbra | 10.7% |
| COOCooper Companies | 13.5% |
| ALGNAlign Technology | 10.0% |
| GMEDGlobus Medical | 17.0% |
| PODDInsulet | 12.3% |
| Peer median | 17.0% |
Where Becton, Dickinson and ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Becton, Dickinson and
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.